PhRMA, EFPIA Pitch Enhanced Appraisal Model for Japan HTA Plan; Chuikyo Reps Acknowledge ICER Limitations

James Feliciano, Acting Chair, Japan-based Executive Committee at PhRMA (left), Kevin Haninger, Vice President, International Advocacy at PhRMA US and European pharma trade groups on December 19 put forward a detailed proposal for Japan’s plan to roll out its version...read more